General Gastro News Articles

Gastro

sponsor

Your Unread Messages

Hello, Mary O'connor
Manage E-mail  |  Logout
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Vitale A et al. – Sorafenib neoadjuvant therapy is cost–effective by comparison with no therapy for T2–HCC patients waiting for LT, particularly for median times to LT under 6 months.

Related Articles

Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1, EFEMP1, a Novel Tumor-Suppressor Gene Detected in Hepatocellular Carcinoma Using Double Combination Array Analysis
Annals of Surgical Oncology, 11/11/09    Relevance Score: 69%

Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma in 14 Patients Undergoing Regular Hemodialysis for End-Stage Renal Disease
American Journal of Roentgenology, 10/09/09    Relevance Score: 69%

Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma
World Journal of Gastroenterology, 10/27/09    Relevance Score: 68%

Cryotherapy for hepatocellular carcinoma
Cochrane Reviews, 10/09/09    Relevance Score: 68%

MicroRNA expression, survival, and response to Interferon in liver cancer
New England Journal of Medicine, 10/08/09    Relevance Score: 68%

Today in Hepatology...keeping you current

Liver functional reserve estimation: state of the art and relevance for local treatments
Journal of Hepato-Biliary-Pancreatic Surgery, 11/23/09

Surgical technique: new advances for expanding indications and increasing safety in liver resection for HCC
Journal of Hepato-Biliary-Pancreatic Surgery, 11/23/09

Noninvasive Positive Pressure Ventilation to Prevent Respiratory Collapse after Extubation: Clinical Case Reports
Transplantation Proceedings, 11/23/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address